China is experiencing an outbreak of a new virus referred to as human metapneumovirus (HMPV). The virus is most likely to ...

The guidelines recommend a 4-month drug regimen for adults and children with drug-susceptible TB, and a 6-month regimen for those with drug-resistant TB.

SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.

Nepal has confirmed two additional cases of mpox among migrant workers, according to health authorities on Friday. With the ...

As the world continues to recover from the devastating effects of the Covid-19 pandemic, experts are now warning about ...

A new laboratory has been created in Wiltshire to boost the UK's ability to fight future pandemics. The Diagnostic ...

Surveillance data from the Centers for Disease Control and Prevention (CDC) indicate a spike in norovirus outbreaks in the ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...

Childhood vaccination rates are on the decline at a time when Robert F. Kennedy Jr. could lead the Health and Human Services ...

Siga Technologies (SIGA)’ antiviral treatment Tepoxx, has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, as ...